Integrin-Mediated Targeted Cancer Therapy Using c(RGDyK)-Based Conjugates of Gemcitabine.
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
13 01 2022
13 01 2022
Historique:
pubmed:
31
12
2021
medline:
8
2
2022
entrez:
30
12
2021
Statut:
ppublish
Résumé
c(RGDyK)-based conjugates of gemcitabine (GEM) with the carbonate and carbamate linkages in the 6-OH group of GEM were synthesized for the targeted delivery of GEM to integrin α
Identifiants
pubmed: 34967607
doi: 10.1021/acs.jmedchem.1c01468
doi:
Substances chimiques
Antimetabolites, Antineoplastic
0
Integrins
0
Peptides, Cyclic
0
cyclic arginine-glycine-aspartic acid peptide
0
Deoxycytidine
0W860991D6
Gemcitabine
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM